Yuchen Bai

Yuchen is a leader in computational biology, with more than 20 years of experience in the pharmaceutical industry (Pfizer, GSK, Janssen and Autolus). He has been working in multiple therapeutic areas such as oncology, immunology and neuroscience across the entire drug development pipeline. The therapeutic modalities that Yuchen has been working on include small molecules, antibodies and cell therapies. Yuchen has extensive experience in next-generation sequencing, multi-omics data analyses, and translational medicine. Recently he has adopted the single-cell omics approach in order to take a deep dive into disease biology and treatment. Yuchen holds a Ph.D. in Molecular Biology from Rutgers University, a Medical Degree from Tianjin Medical University, a MS in Computer Science from Villanova University, and a BS in Biology from Tsinghua University.